Profile data is unavailable for this security.
About the company
Enveric Biosciences, Inc. is a biotechnology company. The Company is engaged in the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety and addiction disorders. The Company, through Psybrary has created a robust intellectual property (IP) portfolio of new chemical entities for specific mental health indications. Its lead program, the EVM201 Series, comprises synthetic prodrugs of the active metabolite, psilocin. It is developing the first product from the EVM201 Series, EB-002, for the treatment of psychiatric disorders. The Company is also advancing its second program, the EVM301 Series, EB 003, which is an approach to the treatment of difficult-to-address mental health disorders. Within the Psybrary, it has three different types of molecules, Generation 1 (classic psychedelics), Generation 2 (pro-drugs), and Generation 3 (new chemical entities). It has created over 1,000 novel psychedelic molecular compounds and derivatives.
- Revenue in USD (TTM)0.00
- Net income in USD-10.59m
- Incorporated1994
- Employees7.00
- LocationEnveric Biosciences Inc4851 Tamiami Trail N, Suite 200NAPLES 34103United StatesUSA
- Phone+1 (239) 302-1707
- Fax+1 (732) 243-9254
- Websitehttps://www.enveric.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chromocell Therapeutics Corp | 0.00 | -8.98m | 3.45m | 4.00 | -- | 3.06 | -- | -- | -1.66 | -1.66 | 0.00 | 0.196 | 0.00 | -- | -- | 0.00 | -440.01 | -- | -- | -- | -- | -- | -- | -- | -- | -7.20 | 0.00 | -- | -- | -- | -200.20 | -- | -- | -- |
Theriva Biologics Inc | 0.00 | -22.27m | 3.50m | 21.00 | -- | 1.33 | -- | -- | -1.25 | -1.25 | 0.00 | 1.23 | 0.00 | -- | -- | 0.00 | -41.30 | -36.95 | -48.49 | -40.16 | -- | -- | -- | -- | -- | -- | 0.0056 | -- | -- | -- | 8.37 | -- | 95.91 | -- |
ENDRA Life Sciences Inc | 0.00 | -9.57m | 3.50m | 21.00 | -- | 0.0311 | -- | -- | -45.63 | -45.63 | 0.00 | 6.21 | 0.00 | -- | -- | 0.00 | -97.17 | -132.00 | -117.34 | -157.28 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 23.67 | -- | -19.46 | -- |
TNF Pharmaceuticals Inc | 0.00 | -7.07m | 3.56m | 9.00 | -- | 0.153 | -- | -- | -5.53 | -5.53 | 0.00 | 10.28 | 0.00 | -- | -- | 0.00 | -25.59 | -76.20 | -31.13 | -84.38 | -- | 7.64 | -- | -4,290.96 | -- | -- | 0.00 | -- | -- | -- | 49.15 | -- | -- | -- |
Hepion Pharmaceuticals Inc | 0.00 | -28.37m | 3.61m | 22.00 | -- | 1.93 | -- | -- | -6.49 | -6.49 | 0.00 | 0.6142 | 0.00 | -- | -- | 0.00 | -133.45 | -61.43 | -167.53 | -68.82 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -7.92 | -- | -- | -- |
Artelo Biosciences Inc | 0.00 | -10.44m | 3.62m | 5.00 | -- | 0.4953 | -- | -- | -3.33 | -3.33 | 0.00 | 2.26 | 0.00 | -- | -- | 0.00 | -82.83 | -- | -88.23 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 7.87 | -- | -- | -- |
Cell MedX Corp | 0.00 | -142.49k | 3.66m | 0.00 | -- | -- | -- | -- | -0.0021 | -0.0021 | 0.00 | -0.0028 | 0.00 | -- | -- | -- | -190.76 | -703.78 | -- | -- | -- | 84.03 | -- | -2,996.54 | -- | -4.35 | -- | -- | -100.00 | -- | 71.22 | -- | -- | -- |
Oncternal Therapeutics Inc | 1.85m | -35.97m | 3.69m | 27.00 | -- | 0.2342 | -- | 2.00 | -12.19 | -12.19 | 0.6254 | 5.32 | 0.0495 | -- | -- | 68,370.37 | -96.40 | -49.40 | -116.52 | -54.51 | -- | -- | -1,948.70 | -1,342.98 | -- | -- | 0.00 | -- | -47.32 | -- | 10.62 | -- | -- | -- |
Silexion Therapeutics Corp | 0.00 | -523.87k | 3.69m | 0.00 | -- | 0.5765 | -- | -- | -0.1403 | -0.1403 | 0.00 | 0.6559 | 0.00 | -- | -- | -- | -3.13 | -- | -3.77 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -54.96 | -- | -- | -- |
Enveric Biosciences Inc | 0.00 | -10.59m | 3.70m | 7.00 | -- | 0.6048 | -- | -- | -3.67 | -3.67 | 0.00 | 0.6862 | 0.00 | -- | -- | 0.00 | -133.67 | -104.94 | -206.10 | -156.88 | -- | -- | -- | -243.54 | -- | -- | 0.00 | -- | -- | -- | 7.14 | -- | -- | -- |
Bone Biologics Corp | 0.00 | -5.12m | 3.73m | 2.00 | -- | 0.805 | -- | -- | -10.26 | -10.26 | 0.00 | 2.21 | 0.00 | -- | -- | 0.00 | -94.66 | -98.31 | -119.03 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -502.76 | -- | -- | -- |
CTT Pharmaceutical Holdings Inc | 0.00 | -1.67m | 3.75m | 0.00 | -- | 2.02 | -- | -- | -0.0822 | -0.0822 | 0.00 | 0.0346 | 0.00 | -- | -- | -- | -317.28 | 13.49 | -448.83 | 304.48 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -3,454.52 | -- | -- | -- |
Notable Labs Ltd | 313.00k | -16.74m | 3.77m | 16.00 | -- | 0.5244 | -- | 12.04 | -2.47 | -2.47 | 0.046 | 0.7439 | 0.0176 | -- | -- | 19,562.50 | -93.89 | -52.02 | -120.26 | -62.09 | 37.70 | 60.19 | -5,346.97 | -3,636.93 | -- | -- | 0.0405 | -- | -52.89 | -11.93 | 65.13 | -- | -50.69 | -- |
Azitra Inc | 408.20k | -9.96m | 3.77m | 10.00 | -- | 0.2751 | -- | 9.24 | -12.12 | -12.12 | 0.1151 | 1.80 | 0.0595 | -- | 1.83 | 40,820.00 | -145.30 | -- | -194.72 | -- | -- | -- | -2,440.46 | -- | -- | -- | 0.0191 | -- | 141.55 | -- | 6.02 | -- | -- | -- |
Palisade Bio Inc | 0.00 | -14.17m | 3.87m | 9.00 | -- | 0.3177 | -- | -- | -20.07 | -20.07 | 0.00 | 10.30 | 0.00 | -- | -- | 0.00 | -90.97 | -132.36 | -109.07 | -165.45 | -- | -- | -- | -27,892.32 | -- | -972.73 | 0.0339 | -- | -- | -0.7814 | 13.74 | -- | 18.53 | -- |
Synaptogenix Inc | 0.00 | -3.45m | 3.90m | 5.00 | -- | 0.1982 | -- | -- | -3.89 | -3.89 | 0.00 | 14.99 | 0.00 | -- | -- | 0.00 | -5.54 | -40.33 | -6.89 | -43.36 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -142.17 | -- | -3.21 | -- |
Holder | Shares | % Held |
---|---|---|
AdvisorShares Investments LLCas of 30 Jun 2024 | 317.05k | 4.09% |
HRT Financial LLCas of 31 Mar 2024 | 63.03k | 0.81% |
Geode Capital Management LLCas of 30 Jun 2024 | 44.66k | 0.58% |
Citadel Securities LLCas of 31 Mar 2024 | 40.10k | 0.52% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 29.58k | 0.38% |
G1 Execution Services LLCas of 31 Mar 2024 | 18.25k | 0.24% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 18.20k | 0.24% |
Two Sigma Investments LPas of 31 Mar 2024 | 15.40k | 0.20% |
Virtu Americas LLCas of 30 Jun 2024 | 13.79k | 0.18% |
Tower Research Capital LLCas of 31 Mar 2024 | 12.28k | 0.16% |